L'Oréal

The company began with a technical product rather than a marketing idea. In July 1909 Schueller, a trained chemist, registered his firm to sell the synthetic hair dyes he had developed, a formula he sold to Parisian hairdressers. That focus on hair colour remained central to the business for decades and still anchors one of its largest product categories today.

L'Oréal describes its history as a long, continuous commitment to a single field. "For over a century we have been dedicated to one sole vocation: creating beauty," the company states on its corporate site [2]. In practice, the group's expansion has come as much through acquisition as through its own laboratories. An early landmark was 1984, when L'Oréal took a controlling stake in the American cosmetics house Helena Rubinstein, a move that broadened its reach in prestige skincare and makeup [3]. From the late twentieth century onward the pace of acquisitions accelerated, adding drugstore, luxury, professional and dermatological names to what had started as a hair-dye maker.

The group's stated purpose today reaches beyond a single category. Alongside its ambition to "create the beauty that moves the world", L'Oréal says it aims to offer "the best of beauty in terms of quality, efficacy, safety, sincerity and responsibility". That framing of safety and responsibility sits next to a portfolio that now runs from inexpensive supermarket ranges to designer fragrance.

According to L'Oréal, its brands are managed within four divisions, each aimed at a different distribution channel [2].

The Consumer Products Division covers mass-market ranges sold largely through supermarkets and drugstores, including L'Oréal Paris, Garnier, Maybelline New York, NYX Professional Makeup and the nail brand Essie. The Luxe Division holds the group's prestige and designer names, among them Lancôme, Yves Saint Laurent, Giorgio Armani and Kiehl's. The Professional Products Division serves salons and hairdressers through L'Oréal Professionnel, Redken and Kérastase. The Dermatological Beauty Division groups the pharmacy- and science-oriented skincare brands, including La Roche-Posay, Vichy, CeraVe and SkinCeuticals.

Beyond these anchor names, the wider portfolio includes long-held European brands such as Biotherm, Mixa and Carita; the makeup and skincare labels IT Cosmetics and NYX Professional Makeup; and a series of more recent additions including Thayers, Aesop, Youth To The People, Medik8, Atelier Cologne, Color Wow and the fragrance house Creed. L'Oréal also produces and sells fragrance and beauty lines under long-term licences from fashion houses, including Ralph Lauren, Cacharel and Guy Laroche.

Much of L'Oréal's growth has been driven by a steady stream of acquisitions that extended it into new categories and price tiers. In 2006 the group bought the British ethical-beauty retailer The Body Shop for £562 million; it held the chain for about a decade before divesting it to the Brazilian company Natura in 2017 [3].

The group has also concentrated on prestige and designer beauty. In 2008 it acquired YSL Beauté for roughly $1.8 billion, folding the Yves Saint Laurent fragrance and cosmetics business into its luxury arm [3]. Two years later, in 2010, it added the American nail-polish brand Essie to its consumer range. Makeup and skincare followed: L'Oréal bought NYX Cosmetics in 2014, the colour-cosmetics brand IT Cosmetics for $1.2 billion in 2016, and the dermatologist-developed skincare line CeraVe, together with AcneFree and Ambi, for $1.3 billion in 2017 [3].

The year 2014 was especially active. Alongside NYX, the group acquired the Chinese facial-mask company Magic Holdings for about $840 million and the French professional skincare brands Carita and Decléor for €227.5 million, deepening its presence in both the Asian mass market and the European professional channel [3].

More recent deals have leaned toward natural, luxury and independent labels. In June 2020 the group signed an agreement to acquire Thayers Natural Remedies, a US natural-skincare brand [5]. In 2023 it bought the Australian luxury brand Aesop for $2.53 billion [3]. In October 2025 L'Oréal announced a roughly €4 billion agreement to acquire the high-end fragrance house Creed, which the Kering group had itself taken over in 2023, alongside 50-year licences to develop the beauty and fragrance lines of the Kering fashion brands Balenciaga, Bottega Veneta and Gucci [4]. Trade press reported the deal was expected to complete in the first half of 2026.

L'Oréal is a publicly traded company, listed on Euronext Paris under the ticker symbol OR, with a secondary quotation on the US OTC Markets under the ticker LRLCF [1]. Even so, a large share of its equity remains in a small number of hands. As of 31 December 2023, the founding Bettencourt family held about 34.73% of the shares and Nestlé about 20.13%, according to figures reported by Wikipedia [3]. The remainder was split between international and French institutional investors, individual shareholders and employees. The combination of a founding-family stake and a long-standing corporate shareholder in Nestlé has given the group an unusually concentrated ownership structure for a company of its size.